Skip to content
StockMarketAgent
Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

NSE/LOTUSEYE stock hub

NSE/LOTUSEYE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

NSE/LOTUSEYEis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
2.4B
National Stock Exchange of India
Market data

Live price

Current market quote for this ticker.

Current price
NSE/LOTUSEYE
In the news

Latest news · NSE/LOTUSEYE

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 24.9P50 32.4P75 45.7
Trailing P/E371.1
P25 24.8P50 35.9P75 56.9
ROEn/a
P25 6.3P50 13.6P75 18.1
ROIC0.9
P25 4.1P50 10.3P75 17.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All NSE/LOTUSEYE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
180
Groups with data
10
Currency
INR
Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
India
Country code
IN
Employees
348
Employees Change
12%
Employees Change Percent
3.57
Enterprise value
INR 2.4B
Exchange
National Stock Exchange of India
Financial currency
INR
First seen
2026-05-10
Industry
Medical Care Facilities
Isin
INE947I01017
Last refreshed
2026-05-10
Market cap
INR 2.4B
Price
INR 116
Price currency
INR
Rev Per Employee
1,483,258.62x
Sector
Healthcare
Sic
8090
Symbol
nse/LOTUSEYE
Website
https://www.lotuseye.org

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

11
MetricValue
Earnings Yield
0.27%
EV Earnings
373.45x
EV/EBIT
218.67x
EV/EBITDA
75.37x
EV/Sales
4.72x
P/B ratio
3.99x
P/E ratio
371.07x
P/S ratio
4.69x
PE Ratio10 Y
137.19x
PE Ratio3 Y
151.13x
PE Ratio5 Y
106.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

20
MetricValue
EBIT Margin
2.16%
EBITDA Margin
4.22%
Gross margin
20.54%
Gross Profit
INR 106M
Gross Profit Growth
-9.31%
Gross Profit Growth Q
11.27%
Gross Profit Growth3 Y
-10.45%
Gross Profit Growth5 Y
10.92%
Net Income
INR 6.5M
Net Income Growth
27.6%
Net Income Growth Years
0%
Net Income Growth3 Y
-45.23%
Pretax Margin
2.46%
Profit Margin
1.26%
Profit Per Employee
INR 18,744
Profitable Years
10
Roa5y
2.85
Roe5y
4.41
ROIC
0.92
Roic5y
4.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

16
MetricValue
Cagr10y
21.74%
Cagr15y
17.1%
Cagr1y
51.4%
Cagr3y
18.47%
Cagr5y
22.51%
Div CAGR3
0%
Div CAGR5
0%
EPS Growth
31.7
EPS Growth Years
0
EPS Growth3 Y
-44.98
Revenue Growth
5.49x
Revenue Growth Q
10.64x
Revenue Growth Quarters
7x
Revenue Growth Years
4x
Revenue Growth3 Y
3.58x
Revenue Growth5 Y
11.49x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

13
MetricValue
Cash
INR 32.5M
Debt
INR 48M
Debt EBITDA
INR 1.48
Debt Equity
INR 0.08
Equity
INR 606.2M
Interest Coverage
1.79
Net Cash
INR -15.5M
Net Cash By Market Cap
INR -0.64
Net Debt EBITDA
INR 0.71
Net Debt Equity
INR 0.03
Tangible Book Value
INR 603.8M
Tangible Book Value Per Share
INR 31.29
WACC
7.84

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
3.11%
Dividend per share
INR 0
Last Dividend
INR 0.5

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
614.94%
1Y total return
51.36%
200-day SMA
111.1
3Y total return
66.29%
50-day SMA
110.3
50-day SMA vs 200-day SMA
50under200
5Y total return
175.95%
All Time High
147
All Time High Change
-21.33%
All Time High Date
2026-01-30
All Time Low
4.5
All Time Low Change
2,470%
All Time Low Date
2013-08-19
ATR
6.09
Beta
0.66
Beta1y
0.16
Beta2y
0.55
Ch YTD
-3.01
High
117.7
High52
147
High52 Date
2026-01-30
High52ch
-21.33%
Low
115.2
Low52
67.72
Low52 Date
2025-06-19
Low52ch
70.78%
Ma50ch
4.83%
Price vs 200-day SMA
4.13%
RSI
53.06
RSI Monthly
57.62
RSI Weekly
53.03
Sharpe ratio
0.93x
Sortino ratio
1.65
Total Return
3.11%
Tr YTD
-3.01
Tr15y
967.72%
Tr1m
9.54%
Tr1w
-0.66%
Tr3m
-5.34%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

4
MetricValue
Operating Income
INR 11.1M
Operating Income Growth
1,213.7
Operating Income Growth3 Y
-38.48
Operating margin
2.16

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
4,724,257%
Shares Insiders
52.76%
Shares Institutions
2.41%
Shares Out
20,796,330
Shares Qo Q
3.91%
Shares Yo Y
-3.11%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

48
MetricValue
Average Volume
16,693.35x
Bv Per Share
31.41
Ch10y
576.3
Ch15y
910
Ch1m
9.54
Ch1w
-0.66
Ch1y
51.36
Ch3m
-5.34
Ch3y
65.33
Ch5y
169.3
Ch6m
-4.6
Change
-1.15%
Change From Open
-0.39
Close
117
Days Gap
-0.76
Depreciation Amortization
10,646,250
Dollar Volume
886,110.3
Earnings Date
2026-05-26
EBIT
INR 11.1M
EBITDA
INR 21.8M
EPS
INR 0.32
F Score
1
Fiscal Year End
March
Founded
1,989
Graham Number
15.01577
Graham Upside
-87.02
Income Tax
INR 6.2M
Is Primary Listing
1
Last Earnings Date
2026-02-11
Last Report Date
2025-12-31
Lynch Fair Value
INR 1.6
Lynch Upside
-98.62
Ma150
115.7
Ma150ch
-0.07%
Ma20
115.4
Ma20ch
0.2%
Next Earnings Date
2026-05-26
Open
116.1
Position In Range
18.07
Price Date
2026-05-08
Price EBITDA
INR 111
Ptbv Ratio
4.01
Relative Volume
0.45x
Revenue
516,174,000x
Tax By Revenue
1.2x
Tax Rate
48.63%
Tr6m
-4.6%
Volume
7,662
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does NSE/LOTUSEYE pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/LOTUSEYE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+51.4%
S&P 500 1Y: n/a
3Y total return
+66.3%
S&P 500 3Y: n/a
5Y total return
+175.9%
S&P 500 5Y: n/a
10Y total return
+614.9%
S&P 500 10Y: n/a
Ownership

Who owns NSE/LOTUSEYE?

Insider, institutional, and short-interest positioning.

Institutional ownership
+2.4%
Share of float held by funds and institutions
Insider ownership
+52.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-3.1%
Negative means the company is buying back shares.
Technical

NSE/LOTUSEYE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
53.1
Neutral momentum band
Price vs 200-day MA
+4.1%
50/200-day relationship not available
Beta (5Y)
0.66
Less volatile than the market
Sharpe ratio
0.93
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About NSE/LOTUSEYE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/LOTUSEYE stock rating?

nse/LOTUSEYE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/LOTUSEYE analysis?

The full report lives at /stocks/nse/LOTUSEYE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/LOTUSEYE?

The latest report frames nse/LOTUSEYE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/LOTUSEYE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

nse/LOTUSEYE stock profile: metrics, valuation and analysis | ИИ-агент фондового рынка